APREA THERAPEUTICS INC (APRE)
US03836J2015 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.71M | -14.29M | -112.66M | -37.13M | -53.48M | |||
| Depreciation Amortization | 13.21K | 7.05K | 0.00 | 10.00K | 30.00K | |||
| Change In Working Capital | -912.90K | 1.62M | -1.76M | -8.33M | 5.57M | |||
| Other non cash items | 483.04K | 483.39K | 89.41M | 7.76M | 6.07M | |||
| OPERATING CASH FLOW | -13.13M | -12.18M | -25.01M | -37.69M | -41.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -93.09K | 0.00 | 0.00 | -30.00K | |||
| INVESTING CASH FLOW | N/A | -93.09K | 0.00 | 0.00 | -30.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 16.00M | 5.79M | 680.00K | 1.75M | 150.00K | |||
| Other Financing Activity | -1.29M | -648.93K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 14.71M | 5.14M | 680.00K | 1.75M | 150.00K | |||
| Exchange Rate Effect | -60.81K | -8.40K | 40.00K | 0.00 | 610.00K | |||
| CHANGE IN CASH | 1.41M | -7.14M | -24.29M | -35.94M | -41.07M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.13M | -12.18M | -25.01M | -37.69M | -41.80M | |||
| Capital Expenditure | N/A | -93.09K | 0.00 | 0.00 | -30.00K | |||
| FREE CASH FLOW | -13.23M | -12.27M | -25.01M | -37.69M | -41.83M | |||
All data in USD